Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gut 2023-03, Vol.73 (4), p.712-714
Hauptverfasser:	Zhang, Eva, Nguyen, Thi H O, Allen, Lilith F, Kedzierski, Lukasz, Rowntree, Louise C, Chang, So Young, Zhang, Wuji, Habel, Jennifer R, Foo, Isabelle J, Menon, Tejas, Mitchell, Jeni, Leong, Rupert W, Bond, Katherine, Williamson, Deborah A, Kedzierska, Katherine, Christensen, Britt
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Coronaviruses COVID-19 COVID-19 vaccines Grants IMMUNE RESPONSE IMMUNOLOGY Infections INFLAMMATORY BOWEL DISEASE Inflammatory bowel diseases Lymphocytes Lymphocytes T PostScript Severe acute respiratory syndrome coronavirus 2 TNF Tumor necrosis factor Tumor necrosis factor-TNF
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!